Cytosorbents (CTSO) Raw Materials (2023 - 2026)
Cytosorbents posted quarterly Raw Materials of $552000.0 for Q1 2026, up 0.95% year-on-year from $546805.0 in Q1 2025, and down 26.5% on a QoQ basis from $751000.0 in Q4 2025.
Cytosorbents (CTSO) has 4 years of Raw Materials data on file, last reported at $552000.0 in Q1 2026.
- For the quarter ending Q1 2026, Raw Materials rose 0.95% year-over-year to $552000.0; the trailing twelve-month figure through Mar 2026 stood at $552000.0 (up 0.95% YoY), and the FY2025 full-year result was $751000.0, up 31.75% from the prior year.
- Raw Materials for Q1 2026 stood at $552000.0, down from $751000.0 in the prior quarter.
- Across five years, Raw Materials topped out at $751000.0 in Q4 2025 and bottomed at $491000.0 in Q2 2025.
- The 4-year median for Raw Materials is $565000.0 (2025), against an average of $594515.1.
- The widest annual swing landed in 2024, when Raw Materials decreased 16.89%; it then jumped 31.75% in 2025.
- A 4-year view of Raw Materials shows it stood at $685801.0 in 2023, then fell by 16.89% to $570000.0 in 2024, then jumped by 31.75% to $751000.0 in 2025, then fell by 26.5% to $552000.0 in 2026.
- The last three Raw Materials figures came in at $552000.0 (Q1 2026), $751000.0 (Q4 2025), and $565000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 552,000.00 |
| Dec 31, 2025 | 751,000.00 |
| Sep 30, 2025 | 565,000.00 |
| Jun 30, 2025 | 491,000.00 |
| Mar 31, 2025 | 546,805.00 |
| Dec 31, 2024 | 570,000.00 |
| Dec 31, 2023 | 685,801.00 |